IGF2 and cancer: Specifically, through the present retrospective analysis of the reported cases of cancer-associated hypoglycemia (Figure 1 and Table 1), we found that secreted-IGF-II constitutes the absolute majority (95%, 171 out of 180) of the associated IGF.